Sequential treatment with rmIL-3 or simultaneous treatment with rmIL-3 or rhIL-11 with thrombopoietin (TPO) fails to enhance in vivo neonatal rat thrombocytopoiesis

Experimental Hematology

Volumn 25, Issue 9, 1997, Pages 1005-1012

  Van de Ven, C ^a   Fernandez, G W ^a   Herbst, T ^a   Knoppel, A ^a   Cairo, M S ^a  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

Interleukin 11; Interleukin 3; Megakaryocytopoiesis; Thrombocytopoiesis; Thrombopoietin

Indexed keywords

RECOMBINANT INTERLEUKIN 11; RECOMBINANT INTERLEUKIN 3; THROMBOPOIETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; INTRAVENOUS DRUG ADMINISTRATION; MEGAKARYOPOIESIS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPOIESIS;

ANIMALS; ANIMALS, NEWBORN; BLOOD PLATELETS; BONE MARROW CELLS; FEMALE; GRANULOCYTES; HEMATOPOIESIS; HUMANS; INTERLEUKIN-11; INTERLEUKIN-3; MACROPHAGES; MICE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; THROMBOPOIETIN;

ANIMALIA;

EID: 0030879789     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)